Generally well tolerated under clinical supervision.
Common mild reactions: injection-site soreness, lightheadedness, flushing, or transient nausea.
Potential risks: electrolyte changes, interactions with medications, or exacerbation of underlying conditions in rare cases.
Not suitable for everyone: pregnancy, breastfeeding, certain medical conditions, or concurrent medications may contraindicate NAD+ therapy.
Full medical history and medication list should be disclosed prior to treatment.
Initial consultation and medical assessment with a qualified clinician.
Loading phase: Many protocols include a series of consecutive daily or several-times-weekly injections.
Maintenance phase: Periodic booster injections tailored to individual goals and response.
Protocols vary widely; dosing and duration are personalized by a healthcare professional.
